High Throughput News and Research

RSS

Host tissue T cells play a previously unappreciated role in acute graft-versus-host disease

Allogenic hematopoietic stem cell transplantation (HSCT) is a procedure that infuses a donor's healthy blood-forming stem cells into a recipient as part of a potentially curative therapy for cancer.

28 Aug 2020

Manipulating 3D Printed Organoid Microenvironments

Organoids are 3-dimensional (3D) clusters of stem cells that come together and emulate the microenvironment within individual organs, whether that be liver, kidney, heart, gut or other specific organs.

From Manchester BIOGEL 28 Aug 2020

SARS discovery boots search for COVID-19 drugs

An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19.

27 Aug 2020

Advances in Virus Epigenetics

Growing evidence shows viruses exploit epigenetic processes to control their life cycles but epigentic regulation of viral infections is not fully understood.

From Chromatrap® - Porvair Sciences Ltd 25 Aug 2020

Raccoon dogs potential intermediate host for SARS-CoV-2

Researchers at the Friedrich Loeffler Institute in Germany have conducted a study demonstrating that raccoon dogs were a potential intermediate host in the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

23 Aug 2020

New COVID-19 pooling test detects asymptomatic carriers

A new peer-reviewed study published in Science Advances confirms the success of a new COVID-19 pooling test that identifies all positive subjects, including asymptomatic carriers, in a single round of testing.

21 Aug 2020

New bioluminescent reporter developed to track DNA double stranded break repair

A new bioluminescent reporter that tracks DNA double stranded break repair in cells has been developed by researchers from Massachusetts General Hospital and the Academia Sinica in Taiwan.

21 Aug 2020

Preexisting drug shows promise as a weapon against SARS-CoV-2 virus

First appearing in late 2019 in Wuhan City, China, the SARS-CoV-2 virus continues to cause sickness and death across the globe.

14 Aug 2020

Vela Diagnostics' coronavirus PCR test receives Emergency Use Authorization from FDA

Vela Diagnostics announced that the manual version of its coronavirus PCR test has obtained Emergency Use Authorization from the U.S. Food and Drug Administration.

6 Aug 2020

Launching a rapid test for COVID-19

Professor Zhanfeng Cui from the University of Oxford speaks to News-Medical about his research into COVID-19, and how he developed a rapid COVID-19 test.

5 Aug 2020

From swab to sequencing - scalable method for identifying SARS-CoV-2

A research group headed by Stanford University scientists has developed a scalable, high throughput method to generate high fidelity whole genome and HLA sequencing, viral genomes, and representation of human transcriptome from single nasopharyngeal swabs of coronavirus disease (COVID19) patients. Their results are published on the medRxiv preprint server.

30 Jul 2020

New technology could speed up drug discovery to fight tuberculosis

A new technology that combines high throughput imaging and machine learning could speed discovery of drugs to fight tuberculosis, which for generations has killed more people worldwide than any other disease caused by a single agent-;4,000 people every day.

23 Jul 2020

Analytik Jena Web Weeks – Analytik Jena launches new web seminar series for biomolecular applications, lab automation, and liquid handling

Analytik Jena is launching its brand new, English-language web seminar series “Analytik Jena Web Weeks” starting July 29, 2020. Until the end of the year, application specialists and product experts from Analytik Jena will present methods, technology solutions, and tips and tricks to make everyday laboratory work more efficient. Topics range from nucleic acid extraction, PCR, qPCR to liquid handling and laboratory automation.

From Analytik Jena US 23 Jul 2020

Texas A&M researcher awarded $5 million CPRIT grant to further cancer studies

On May 20, Dr. Tanmay Lele, professor in the Department of Biomedical Engineering at Texas A&M University, received a $5 million Recruitment of Established Investigators grant from the Cancer Prevention and Research Institute of Texas to further knowledge about cancer and how it progresses.

22 Jul 2020